Qingfa Bu
Impact in
-
- interferon and immune responses
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- interferon and immune responses 4
- Immune cells in cancer 2
-
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Haoming Zhou (10 shared papers)Wantong Su (5 shared papers)Lei Li (3 shared papers)Ling Lü (7 shared papers)Xun Wang (2 shared papers)Zheng Liu (2 shared papers)Qi Wang (2 shared papers)Mingming Wang (2 shared papers)
- Journals
- JHEP Reports (3 papers)Journal of Hepatology (2 papers)Redox Biology (1 paper)Advanced Science (1 paper)Clinical and Molecular Hepatology (1 paper)
- Partner nations
- ChinaBangladesh
In The Last Decade
Qingfa Bu
13 papers receiving 649 citations
Qingfa Bu's Hit Papers
Peers
Comparison fields: 5 of 65
- Immunology 226
- Hepatology 71
- Epidemiology 165
- Cancer Research 57
- Cell Biology 65
Countries citing papers authored by Qingfa Bu
This map shows the geographic impact of Qingfa Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfa Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfa Bu more than expected).
Fields of papers citing papers by Qingfa Bu
This network shows the impact of papers produced by Qingfa Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfa Bu. The network helps show where Qingfa Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingfa Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury Hit paper breakdown → | 2022 | 278 |
| 2 | 2022 | 111 | |
| 3 | 2022 | 89 | |
| 4 | 2023 | 68 | |
| 5 | 2021 | 30 | |
| 6 | 2023 | 26 | |
| 7 | 2024 | 16 | |
| 8 | 2024 | 15 | |
| 9 | 2024 | 10 | |
| 10 | 2025 | 5 | |
| 11 | 2025 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2026 | 0 |
About Qingfa Bu
Qingfa Bu is a scholar working on Immunology, Epidemiology, Cancer Research, Endocrinology, Diabetes and Metabolism and Cell Biology, having authored 14 papers that have together received 652 indexed citations. Recurring topics across this work include interferon and immune responses (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (2 papers), Diet, Metabolism, and Disease (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Immune cells in cancer (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Immunology (226 citations), Hepatology (71 citations), Epidemiology (165 citations), Cancer Research (57 citations) and Cell Biology (65 citations). Qingfa Bu has collaborated with scholars based in China and Bangladesh. Frequent co-authors include Haoming Zhou, Wantong Su, Lei Li, Ling Lü, Xun Wang, Zheng Liu, Qi Wang, Mingming Wang, Jinren Zhou and Mu Liu. Their work appears in journals such as JHEP Reports, Journal of Hepatology, Redox Biology, Advanced Science and Clinical and Molecular Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.